Postoperative survival in stage II non-small cell bronchogenic carcinoma;Supervivencia posquirúrgica en el estadio II del carcinoma broncogénico no anaplásico de células pequeñas

Archivos de Bronconeumologia

Volumn 37, Issue 1, 2001, Pages 19-26

  Calvo Medina, V ^a   Padilla Alarcon J ^a   Paris Romeu F ^a   Blasco Armengod, E ^a   Pastor Guillem, J ^a   Garcia Zarza A ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Lung cancer; Stage II; Survival

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; FEMALE; HUMAN; LUNG CARCINOMA; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MALE; MIDDLE AGED; MORTALITY; PATHOLOGY; RETROSPECTIVE STUDY; SURVIVAL RATE;

ADULT; AGED; CARCINOMA, BRONCHOGENIC; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 0035236140     PISSN: 03002896     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0300-2896(01)75003-x     Document Type: Article

References (68)

1. Mountain CF. A new international staging system for lung cancer. Chest 1986; 89 (Supl 1): 225-233.
2. Mountain CF. Revisions in the international system for staging lung cancer. Chest 1997; 111: 1710-1717.
3. Grupo de Trabajo de la SEPAR. Normativa actualizada (1998) sobre diagnóstico y estadificación del carcinoma broncogénico. Arch Bronconeumol 1998; 34: 437-452.
4. Mountain CF, Dresler CM. Regional lymph node classification for lung cancer staging. Chest 1997; 111: 1718-1723.
5. Naruke T, Suemasu K, Ishikawa S. Lymph node mapping and curability at various levels of metastasis in resected lung cancer. J Thorac Cardiovasc Surg 1978; 76: 832-839.
6. WHO. The World Health Organization histological typing of lung tumors (second edition). Am J Clin Pathol 1982; 77: 123-126.
7. Kaplan EL, Meier P. Non parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
8. a ed.). Madrid: McGraw-Hill, 1994; 22-54.
9. Mantel N. Evaluation of survival data and two new rank order statistics arising in it as consideration. Cancer Chemother Rep 1966; 50: 163-170.
10. Breslow N. A generalized Kruskal-Wallis test for comparing k samples subject to unequal censorship. Biometrika 1970; 57: 579-594.
11. Tarone R, Ware J. On distribution-free tests for equality of survival distributions. Biometrika 1977; 64: 156-160.
12. Cox DR. Regression model and life tables. J R Stat Soc 1972; 34: 187-220.
13. 0. Arch Bronconeumol 2000; 36: 510-514.
14. Cangemi V, Volpino P, D'Andrea N, Chiarotti F, Tomassini R, Piat G. Results of surgical treatment of stage IIIA non-small cell lung cancer. Eur J Cardiothorac Surg 1995; 9: 352-359.
15. Buccheri G, Ferrigno D. Prognostic factors in lung cancer: tables and comments. Eur Respir J 1994; 7: 1350-1364.
16. Ichinose Y, Yano T, Asoh H, Yokoyama H, Yoshino I, Katsuda Y. Prognostic factors obtained by a pathologic examination in completely resected non-small-cell lung cancer. J Thorac Cardiovasc Surg 1995; 110: 601-605.
17. Padilla J, Calvo V, Peñalver JC, Sales G, Morcillo A. Surgical results and prognostic factors in early non-small cell lung cancer. Ann Thorac Surg 1997; 63: 324-326.
18. Van Velzen E, Snijder RJ, Brutel de la Rivière A, Elbers HR, Van den Bosch JM. Lymph node type as a prognostic factor for survival in T2 N1 M0 non-small cell lung carcinoma. Ann Thorac Surg 1997; 63: 1436-1440.
19. Yano T, Hara N, Ichinose Y, Asoh H, Yokoyama H, Ohta M et al. Local recurrence after complete resection for non-small-cell carcinoma of the lung. Significance of local control by radiation treatment. J Thorac Cardiovasc Surg 1994; 107: 8-12.
20. Barr LC, Baum M. Time to abandon TNM staging of breast cancer? Lancet 1992; 339: 915-917.
21. Ginsberg R, Cox J, Green M, Bülzebruck H, Grunenwald D, Harper P et al. Consensus report: Staging Classification Committee. Lung Cancer 1997; 17 (Supl): 11-13.
22. Inoue K, Sato M, Fujimura S, Sakurada A, Takahashi S, Usuda K et al. Prognostic assessment of 1310 patients with non-small-cell lung cancer who underwent complete resection from 1980 to 1993. J Thorac Cardiovasc Surg 1997; 116: 407-411.
23. Nesbitt JC, Putnam JB, Walsh GL, Roth JA, Mountain CF. Survival in early-stage non-small cell lung cancer. Ann Thorac Surg 1995; 60: 466-472.
24. Trastek VF, Pairolero PC, Piehler JM, Weiland LH, O'Brien PC, Payne WS et al. En bloc (non-chest wall) resection for bronchogenic carcinoma with parietal fixation: factors affecting survival. J Thorac Cardiovasc Surg 1984; 87: 352-358.
25. Pairolero PC, Williams DE, Bergstralh EJ, Piehler JM, Bernatz PE, Payne WS. Postsurgical stage I bronchogenic carcinoma: morbid implications of recurrent disease. Ann Thorac Surg 1984; 38: 331-338.
26. Martini N, Burt ME, Bains MS, McCormack PM, Rusch VW, Ginsberg RJ. Survival after resection of stage II non-small cell lung cancer. Ann Thorac Surg 1992; 54: 460-466.
27. Watanabe Y, Shimizu J, Oda M, Hayashi Y, Watanabe S, Iwa T. Results of surgical treatment in patients with stage IIIA non-small-cell lung cancer. Thorac Cardiovasc Surgeon 1991; 39: 44-49.
28. Naruke T, Goya T, Tsuchiya R, Suemasu K. Prognosis and survival in resected lung carcinoma based on the new international staging system. J Thorac Cardiovasc Surg 1988; 96: 440-447.
29. Padilla J, García A, Pastor J, Peñalver JC, Sales G, Tarrazona V. Factores pronósticos y supervivencia en el tratamiento quirúrgico del carcinoma broncopulmonar no anaplásico de células pequeñas T1N0M0. Cir Esp 1994; 55: 351-353.
30. Ichinose Y, Yano T, Yokohama H, Inoue T, Asoh H, Katsuda Y. The correlation between tumor size and lymphatic vessel invasion in resected peripheral stage I non-small-cell lung cancer. J Thorac Cardiovasc Surg 1994; 108: 684-686.
31. a ed.). Filadelfia: Williams & Wilkins, 1996; 339-350.
32. Martini N, Yellin A, Ginsberg RJ, Bains MS, Burt ME, McCormack PM et al. Management of non-small cell lung cancer with direct mediastinal involvement. Ann Thorac Surg 1994; 58: 1447-1451.
33. Herman SJ. Staging of bronchogenic carcinoma. World J Surg 1993; 17: 694-699.
34. Watanabe Y, Shimizu J, Oda M, Iwa T, Takashima T, Kamimura R et al. Early hilar lung cancer: its clinical aspect. J Surg Oncol 1991; 48: 75-80.
35. Cangemi V, Volpino P, Giuliani A, D'Andrea N, Tomassini R, Piat G. The role of surgery in stage IIIa non-small cell lung cancer. Surgery in IIIa NSCLC. Panminerva Med 1994; 36: 62-65.
36. Zanetti PP, Sorisio V, Baratta V, Amerio GM, Cavanenghi D, Rosa G et al. L'invasione della parete toracica nelle neoplasie polmonari primitive. Minerva Chir 1994; 49: 1263-1268.
37. Rusch VW, Albain KS, Crowley JJ, Rice TW, Lonchyna V, McKenna R Jr et al. Surgical resection of stage IIIA and stage IIIB non-small-cell lung cancer after concurrent induction chemoradiotherapy. A Southwest Oncology Group trial. J Thorac Cardiovasc Surg 1993; 105: 97-104.
38. Ribet M, Al Nashawati G. Cancers bronchiques envahissant la paroi thoracique. Rev Mal Respir 1992; 9: 525-530.
39. Casillas M, París F, Tarrazona V, Padilla J, Paniagua M, Galán G. Surgical treatment of lung carcinoma involving the chest wall. Eur J Cardiothorac Surg 1989; 3: 425-429.
40. Lacquet LK. Present views of the surgical treatment of non-small cell lung cancer. Verh K Acad Geneeskd Belg 1994; 56: 473-493.
41. López L, López-Pujol J, Varela A, Baamonde C, Socas L, Salvatierra A et al. Surgical treatment of stage III non-small cell bronchogenic carcinoma involving the chest wall. Scand J Thorac Cardiovasc Surg 1992; 26: 129-133.
42. McCaughan BC. Primary lung cancer invading the chest wall. Chest Surg Clin North Am 1994; 4: 17-28.
43. Niwa H, Masaoka A, Yamakawa Y, Fukai I, Kiriyama M. Surgical therapy for apical invasive lung cancer: different approaches according to tumor location. Lung Cancer 1993; 10: 63-71.
44. Padovani B, Mouroux J, Seksik L, Chanalet S, Sedat J, Rotomondo C et al. Chest wall invasion by bronchogenic carcinoma: evaluation with MR imaging. Radiology 1993; 187: 33-38.
45. Padilla J, Calvo V, García A, Pastor J, Blasco E, París F. Pronóstico tras resección quirúrgica del carcinoma broncogénico no anaplásico de células pequeñas según la nueva normativa de estadificación: análisis de 1.433 pacientes. Arch Bronconeumol 1999; 35: 483-487.
46. Weksler B, Bains M, Burt M, Downey R, Martini N, Rusch V et al. Resection of lung cancer invading the diaphragm. J Thorac Cardiovasc Surg 1997; 114: 500-501.
47. Watanabe Y, Shimizu J, Oda M, Hayashi Y, Watanabe S, Yakazi U et al. Results in 104 patients undergoing bronchoplastic procedures for bronchial lesions. Ann Thorac Surg 1990; 50: 607-614.
48. Pitz CCM, Brutel de la Rivière A, Elbers HRJ, Westermann CJJ, Van den Bosch JM. Results of resection of T3 non-small cell lung cancer invading the mediastinum or main bronchus. Ann Thorac Surg 1996; 62: 1016-1020.
49. Pairolero PC, Trastek VF, Payne WS. Treatment of bronchogenic carcinoma with chest wall invasion. Surg Clin North Am 1987; 67: 959-964.
50. Allen MS, Mathisen DJ, Grillo HC, Wain JC, Moncure AC, Hilgenberg AD. Bronchogenic carcinoma with chest wall invasion. Ann Thorac Surg 1991; 51: 948-951.
51. Dartevelle P, Macchiarini P. Actuarial five-year survival estimates. J Thorac Cardiovasc Surg 1993; 105: 375-377.
52. Dartevelle PG, Chapelier AR, Macchiarini P, Lenot B, Cerrina J, Le Roy Ladurie F et al. Anterior transcervical-thoracic approach for radical resection of lung tumors invading the thoracic inlet. J Thorac Cardiovasc Surg 1993; 105: 1025-1034.
53. a ed.). Nueva York: Churchill Livingstone Inc., 1995; 887-896.
54. Dartevelle PG. Extended operations for the treatment of lung cancer. Ann Thorac Surg 1997; 63: 12-19.
55. Yano T, Yokoyama H, Inoue T, Asoh H, Tayama K, Ichinose Y. Surgical results and prognostic factors of pathologic N1 disease in non-small-cell carcinoma of the lung. J Thorac Cardiovasc Surg 1994; 107: 1398-1402.
56. Yano T. The location of station 11 pulmonar lymph nodes (reply to the editor). J Thorac Cardiovasc Surg 1995; 109: 403.
57. Shields TW. The location of station 11 pulmonary lymph nodes. J Thorac Cardiovasc Surg 1995; 109: 402-403.
58. Passlick B, Izbicki JR, Kubuschok B, Thetter O, Pantel K. Detection of disseminated lung cancer cells in lymph nodes: impact on staging and prognosis. Ann Thorac Surg 1996; 61: 177-183.
59. Moro D, Nagy Mignotte H, Bolla M, Colonna M, Brichon PY, Brambilla C et al. Evaluation de la survie et des facteurs pronostiques de 2.000 cancers broncho-pulmonaires enregistrés en 10 ans dans une unité multidisciplinaire de cancérologie. Bull Cancer 1997; 84: 155-161.
60. Cueto A, Sánchez A, Ruiz J. Evolución del carcinoma broncogénico resecado: supervivencia a los 5 años. Nuestra experiencia. Arch Bronconeumol 1997; 33: 372-377.
61. Thomas P, Massard G, Sielezneff I, Morati N, Giudicelli R, Garbe L al. Résultats de la chirurgie des cancers bronchiques primitifs non microcellulaires. Analyse rétrospective de 452 exereses. Rev Mal Respir 1992; 9: 531-537.
62. Shah R, Sabanathan S, Richardson J, Mearns AJ, Goulden C. Results of surgical treatment of stage I and II lung cancer. J Cardiovasc Surg Torino 1996; 37: 169-172.
63. Baillet F, Manoux D, Lange J, Homasson JP, Simon JM, Diana C et al. Radiothérapie postopératoire dans le cancer bronchique non à petites cellules. A propos d'une série de 374 cas. Cancer Radiother 1997; 1: 137-142.
64. Daly RC, Trastek VF, Pairolero PC, Murtaugh PA, Huang MS, Allen MS et al. Bronchoalveolar carcinoma: factors affecting survival. Ann Thorac Surg 1991; 51: 368-377.
65. Holmes EC. Treatment of stage II lung cancer (T1N1 and T2N1). Surg Clin North Am 1987; 67: 945-949.
66. Mountain CF, Lukeman JM, Hammar SP. Lung cancer classification: the relationship of disease extent and cell type to survival in a clinical trials population. J Surg Oncol 1987; 35: 147-156.
67. Kadri MA, Dussek JE. Survival and prognosis following resection of primary non small cell bronchogenic carcinoma. Eur J Cardiothorac Surg 1991; 5: 132-136.
68. Bülzebruck H, Bopp R, Drings P, Bauer E, Krysa S, Probst G et al. New aspects in the staging of lung cancer: prospective validation of the International Union Against Cancer TNM classification. Cancer 1992; 70: 1102-1110.